Mostrar el registro sencillo del ítem

dc.contributor.authorBortolotti, Massimo
dc.contributor.authorMaiello, Stefania
dc.contributor.authorFerreras Rodríguez, José Miguel 
dc.contributor.authorIglesias Álvarez, María del Rosario 
dc.contributor.authorPolito, Letizia
dc.contributor.authorBolognesi, Andrea
dc.date.accessioned2023-06-20T07:36:16Z
dc.date.available2023-06-20T07:36:16Z
dc.date.issued2021
dc.identifier.citationToxins, 2021, Vol. 13, Nº. 2, 81es
dc.identifier.issn2072-6651es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/59905
dc.descriptionProducción Científicaes
dc.description.abstractRibosome-inactivating proteins (RIPs) are plant toxins that irreversibly damage ribosomes and other substrates, thus causing cell death. RIPs are classified in type 1 RIPs, single-chain enzymatic proteins, and type 2 RIPs, consisting of active A chains, similar to type 1 RIPs, linked to lectin B chains, which enable the rapid internalization of the toxin into the cell. For this reason, many type 2 RIPs are very cytotoxic, ricin, volkensin and stenodactylin being the most toxic ones. From the caudex of Adenia kirkii (Mast.) Engl., a new type 2 RIP, named kirkiin, was purified by affinity chromatography on acid-treated Sepharose CL-6B and gel filtration. The lectin, with molecular weight of about 58 kDa, agglutinated erythrocytes and inhibited protein synthesis in a cell-free system at very low concentrations. Moreover, kirkiin was able to depurinate mammalian and yeast ribosomes, but it showed little or no activity on other nucleotide substrates. In neuroblastoma cells, kirkiin inhibited protein synthesis and induced apoptosis at doses in the pM range. The biological characteristics of kirkiin make this protein a potential candidate for several experimental pharmacological applications both alone for local treatments and as component of immunoconjugates for systemic targeting in neurodegenerative studies and cancer therapy.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherMDPIes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectPlant toxinses
dc.subjectToxinases
dc.subjectProteins - Synthesises
dc.subjectProteínases
dc.subjectRibosomes - Structurees
dc.subjectApoptosises
dc.subjectLectinses
dc.subjectNeuroblastomaes
dc.subjectPharmacology/Toxicologyes
dc.subject.classificationRibosome-inactivating protein
dc.titleKirkiin: A new toxic type 2 ribosome-Inactivating protein from the caudex of Adenia kirkiies
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2021 The authorses
dc.identifier.doi10.3390/toxins13020081es
dc.relation.publisherversionhttps://www.mdpi.com/2072-6651/13/2/81es
dc.identifier.publicationfirstpage81es
dc.identifier.publicationissue2es
dc.identifier.publicationtitleToxinses
dc.identifier.publicationvolume13es
dc.peerreviewedSIes
dc.description.projectUniversidad de Bolonia y Pallotti Legacies for Cancer Research; Fundación CARISBO - (Project 2019.0539)es
dc.description.projectJunta de Castilla y León - (Grant VA033G19)es
dc.identifier.essn2072-6651es
dc.rightsAtribución 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones
dc.subject.unesco3209 Farmacologíaes
dc.subject.unesco3214 Toxicologíaes
dc.subject.unesco2302 Bioquímicaes


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem